Ortho Development receives FDA 510(k) clearance of hip system with triple-taper stem

Fact checked byGina Brockenbrough, MA

Key takeaways:

Ortho Development Corporation received FDA 510(k) clearance of its Trivicta hip system.
The system utilizes a triple-taper stem to promote ingrowth and stability for patients undergoing total hip arthroplasty.

Ortho Development Corporation announced FDA 510(k) clearance of its Trivicta hip system, according to a company press release.

The Trivicta hip system includes a triple-taper femoral stem to promote ingrowth and stability for a range of patient anatomies, according to the release.

Generic FDA News infographic — Ortho Development Corporation received FDA 510(k) clearance of its Trivicta hip system.

“Trivicta expands our extensive primary hip portfolio and incorporates our philosophy of evolutionary innovation,” Brent Bartholomew, president and CEO of Ortho Development, said in the release. “The system is designed to be versatile enough to address the vast needs of patients and surgeons, accommodating both muscle-sparing and traditional surgical approaches.”

According to the release, the Trivicta hip system will be available on a limited basis in the United States in the second quarter of 2024.

Published by:

Sources/Disclosures

Collapse

Source:

Press Release

Read more

Ortho Development receives FDA 510(k) clearance of hip system with triple-taper stem

Key takeaways:

Related Content